Amgen’s bad luck in lupus may finally be coming to an end. Daxdilimab, a monoclonal antibody acquired from Horizon ...
AstraZeneca has hit what appears to be a minor speed bump in gaining clearance in the U.S. for its subcutaneous (SC) version of lupus treatment Saphnelo. | AstraZeneca will have to negotiate what ...
The company is working with the U.S. regulator to move forward with an updated application, adding a decision is expected in the first half of 2026.
AstraZeneca said on Tuesday that the U.S. health regulator had rejected its application for an easier-to-use version of lupus ...
The FDA has granted Breakthrough Therapy designation for litifilimab for the treatment of cutaneous lupus erythematosus, a chronic autoimmune skin disease.
Lupus is a complex autoimmune disease that can affect many parts of the body, and its symptoms often appear gradually, come and go, or look like those of other conditions. If you think you might have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results